HCW Biologics Stock Scheduled to Reverse Split on Friday, April 11th (NASDAQ:HCWB)

HCW Biologics Inc. (NASDAQ:HCWB) shares are set to reverse split on Friday, April 11th. The 1-40 reverse split was announced on Tuesday, April 1st. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, April 10th.

HCW Biologics Trading Down 4.8 %

NASDAQ:HCWB opened at $0.23 on Monday. The business’s fifty day moving average price is $0.36 and its 200 day moving average price is $0.43. The firm has a market capitalization of $10.21 million, a price-to-earnings ratio of -0.23 and a beta of 0.82. HCW Biologics has a 1-year low of $0.21 and a 1-year high of $2.52.

HCW Biologics (NASDAQ:HCWB) last announced its quarterly earnings data on Friday, March 28th. The company reported ($0.08) earnings per share (EPS) for the quarter. HCW Biologics had a negative return on equity of 2,516.84% and a negative net margin of 1,067.82%. The firm had revenue of $0.40 million for the quarter.

About HCW Biologics

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.